Long‐Term Follow Up in Anti‐Contactin‐1 Autoimmune Nodopathy

Abstract

Patients with anti-CNTN1⁺ autoimmune nodopathy have a characteristic clinical profile. Clinical and immunological relapses are infrequent after successful treatment, suggesting that continuous treatment is unnecessary. Anti-CNTN1 antibodies, sNfL, and sCNTN1 levels are useful to monitor disease status in these patients. ANN NEUROL 2025;97:529-541.